Bashir, BilalHo, Jan HDownie, PaulHamilton, PaulFerns, GordonDatta, DevCegla, JaiminiWierzbicki, Anthony SDawson, CharlotteJenkinson, FionaDelaney, HannahMansfield, MichaelTeoh, YeeMiedzybrodzka, ZosiaHaso, HayaDurrington, Paul NSoran, Handrean2023-06-192023-06-192023-05Bashir, B, Ho, J H, Downie, P, Hamilton, P, Ferns, G, Datta, D, Cegla, J, Wierzbicki, A S, Dawson, C, Jenkinson, F, Delaney, H, Mansfield, M, Teoh, Y, Miedzybrodzka, Z, Haso, H, Durrington, P N & Soran, H 2023, 'Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome : Causes, Clinical Presentation, and Therapeutic Options', Metabolites, vol. 13, no. 5, 621. https://doi.org/10.3390/metabo130506212218-1989PubMedCentral: PMC10224445unpaywall: 10.3390/metabo13050621ORCID: /0000-0003-2890-8136/work/175113394https://hdl.handle.net/2164/20926Funding Information: We acknowledge support from the National Institute for Health Research (NIHR), Manchester Biomedical Research Centre, and the lipid disease fund. Figures were created with BioRender.com .313659380engSDG 3 - Good Health and Well-beingatherosclerosischylomicronaemia syndromehypertriglyceridaemiamicrovascular complicationspancreatitisvolanesorsenQH426 GeneticsQD ChemistryQR MicrobiologyMolecular BiologyBiochemistryEndocrinology, Diabetes and MetabolismNational Institute for Health Research (NIHR)QH426QDQRJournal article10.3390/metabo13050621http://www.scopus.com/inward/record.url?scp=85160336714&partnerID=8YFLogxK135